← back to database
Rhapsody Venture Partners invests exclusively in early-stage hard-science companies addressing industrial problems. It typically writes $500K–$2M first checks, leads seed rounds, and often leads larger follow-on syndicates while helping bring lab innovations to market.
Stage focus
Lead / follow
Ownership target
Specialization
Generalist / Specialist
Specialist
Investing team
- Carsten BoersManaging Partner
- Corrie KavanaughPrincipal
- Jason WhaleyGeneral Partner
- Jessica FreyerPartner
- Mike FuerstmanPartner
- Robert NewmanAssociate
- Sarah HammerAssociate
How to reach them
Notable investments
Apeel Sciences, Adden Energy, AmberSemi, Manus Bio, Magnolia Medical Technologies, Chinova Bioworks, Holiferm, Biophilica, NODAR, Titan Haptics